Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model
Journal
Molecular Cancer Therapeutics
Journal Volume
16
Journal Issue
2
Pages
312-322
Date Issued
2017
Author(s)
Teng K.-Y.
Han J.
Zhang X.
He S.
Wani N.A.
Barajas J.M.
Snyder L.A.
Frankel W.L.
Caligiuri M.A.
Jacob S.T.
Yu J.
Ghoshal K.
SDGs
Publisher
American Association for Cancer Research Inc.
Type
journal article